Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson Q4 2024 Earnings Preview
Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing
Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the look-back and look-ahead on an earnings call,
SmarFinancial: Q4 Earnings Snapshot
KNOXVILLE, Tenn. — KNOXVILLE, Tenn. — SmartFinancial Inc. (SMBK) on Tuesday reported fourth-quarter earnings of $9.6 million. The Knoxville, Tennessee-based bank said it had earnings of 57 cents per share.
Earnings call transcript: Johnson & Johnson Q3 2024 beats EPS forecast
Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The company's revenue also exceeded projections,
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript
Operator Good morning and welcome to Johnson & Johnson's fourth quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference.
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines to go off patent in the coming weeks.
Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.
5h
Tesla Gears Up to Report Q4 Earnings: Here's What to Expect
The Zacks Consensus Estimate for TSLA's fourth-quarter earnings and revenues is pegged at 76 cents per share and $27.61 ...
7h
on MSN
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical ...
Hosted on MSN
1h
Comerica Q4 Earnings Miss Estimates on Lower NII, Fee Income Rises Y/Y
Comerica Incorporated CMA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.2, missing the Zacks Consensus ...
2h
on MSN
Is Netflix Stock Still a Buy After Earnings, Price Hikes?
Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.
1h
How To Earn $500 A Month From GE Aerospace Stock Ahead Of Q4 Earnings
GE Aerospace (NYSE:GE) will release its fourth-quarter financial results before the opening bell on Thursday, Jan. 23.
2d
on MSN
What Analysts Think of P&G Stock Ahead of Earnings
Proctor & Gamble is set to report fiscal second-quarter earnings before the opening bell Wednesday, with analysts calling for ...
8h
Procter & Gamble earnings beat estimates as shoppers buy more household staples
Procter & Gamble on Wednesday reported quarterly earnings and revenue that beat analysts' expectations, thanks to growing ...
14h
SBC-Fueled Cash Flows And Weak Growth Make Snap A Sell Into Earnings
Snap's valuation appears egregious, with EV/EBITDA indicating it's the most expensive among peers. See here to know why we ...
22h
Seagate: Fiscal Q2 Earnings Snapshot
SINGAPORE — SINGAPORE — Seagate Technology Holdings plc (STX) on Tuesday reported fiscal second-quarter earnings of $336 million. On a per-share basis, the Singapore-based company said it had net ...
2h
on MSN
Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.
Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Johnson & Johnson
Procter & Gamble
EPS
Peoples Bancorp
Feedback